FDA Warns Heart Patients Away from Clarithromycin
(MedPage Today) -- Antibiotic appears to raise mortality risk in users with heart disease (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - February 22, 2018 Category: Infectious Diseases Source Type: news
FDA Drug Safety Communication: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease
The U.S. Food and Drug Administration (FDA) is advising caution before prescribing the antibiotic clarithromycin (Biaxin) to patients with heart disease because of a potential increased risk of heart problems or death that can occur years later. Our recommendation is based on our review of the results of a 10-year follow-up study1 of patients with coronary heart disease from a large clinical trial2 that first observed this safety issue. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 22, 2018 Category: Drugs & Pharmacology Source Type: news
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial
This study has led to a Practice Changing Update on DynaMed Plus. It found that clarithromycin plus naproxen plus oseltamivir for 2 days followed by oseltamivir for 3 days may reduce mortality compared to oseltamivir alone for 5 days in hospitalized older adults with influenza A (H3N2) and pneumonia (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 29, 2017 Category: Consumer Health News Source Type: news
These 3 Superbugs Pose The Greatest Risk To Human Health
The World Health Organization is issuing a warning about a group of deadly bacteria: Recently, the WHO released its first-ever list of “priority pathogens,” a list of antibiotic-resistant bacteria that the organization says pose the greatest threat to human health.
The list is divided into three categories: critical-, high- and medium-priority. Three pathogens made it into the critical-priority group. These bacteria are resistant to multiple antibiotics and pose a high risk to people in hospitals and nursing homes, the WHO says.
Multidrug-resistant bacteria, sometimes called “superbugs,” are a ...
Source: Science - The Huffington Post - March 23, 2017 Category: Science Source Type: news
Prevpac (Lansoprazole, Amoxicillin and Clarithromycin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 29, 2016 Category: Drugs & Pharmacology Source Type: news
clarithromycin, Biaxin
Title: clarithromycin, Biaxin < br / > Category: Medications < br / > Created: 12/31/1997 12:00:00 AM < br / > Last Editorial Review: 7/29/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 29, 2016 Category: Drugs & Pharmacology Source Type: news
Two Weeks of PAM Triple Therapy for H pylori as Effective as PACTwo Weeks of PAM Triple Therapy for H pylori as Effective as PAC
Triple therapy combining a proton-pump inhibitor (PPI), amoxicillin, and high-dose metronidazole (PAM) given thrice daily for 14 days provides Helicobacter pylori eradication rates similar to those with triple-therapy regimens containing clarithromycin (PAC), according to a new report. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2016 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Biaxin, Biaxin XL (Clarithromycin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 28, 2016 Category: Drugs & Pharmacology Source Type: news
New Lyme Disease Study Reveals Strong Reporting Bias
This study is a useful contribution to ongoing investigations of how to treat ongoing Lyme disease symptoms among patients who have received the standard 28-day course of doxycycline and continue to experience severe symptoms commonly associated with Lyme disease. This study is also significant because, unlike the majority of Lyme disease-related studies published in peer-reviewed medical journals, it made international headlines in mainstream news outlets. Some publications that specialize in medical and health-related stories covered the story appropriately, such as Medscape, whose headline reads, "Post-Treatment Lyme D...
Source: Healthy Living - The Huffington Post - April 8, 2016 Category: Consumer Health News Source Type: news
Cardiovascular outcomes associated with use of clarithromycin: population based study
This research article looks at current clarithromycin use associated with increased risk of myocardial infarction, arrhythmia, and death compared to current amoxicillin use in adults. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 11, 2016 Category: Consumer Health News Source Type: news
Clarithromycin and Short-term Risk of Cardiovascular EventsClarithromycin and Short-term Risk of Cardiovascular Events
Clarithromycin is associated with an increased short-term risk of cardiovascular morbidity, especially in older patients and those with hypertension or diabetes, according to a new population-based study. Reuters Health Information (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - January 22, 2016 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Two commonly used antibiotics OK during pregnancy
Stephen FellerMONTREAL, Oct. 30 (UPI) -- Researchers found that two of the most commonly used antibiotics -- azithromycin and clarithromycin -- are safe for women to take during pregnancy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 30, 2015 Category: Consumer Health News Source Type: news
Your NEJM Group Today: Torture at CIA "Black Sites", Half Dose of Clarithromycin for H. pylori, New York EM Opportunities (FREE)
By the Editors
NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM Clinical Practice Center: Perspective: According … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 15, 2015 Category: Primary Care Source Type: news
'Modest' Elevated Risk With Clarithromycin Plus Some Statins 'Modest' Elevated Risk With Clarithromycin Plus Some Statins
It was seen for the antibiotic with statins not metabolized via cytochrome P450 3A4, researchers say. Though small, the added risk may be important in practice given how often the drugs are combined. Heartwire (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 29, 2014 Category: Cardiology Tags: Cardiology News Source Type: news
Combining statin with antibiotic can 'increase risk of adverse events'
Combining the antibiotic clarithromycin with some statins increases the risk of adverse events, which may lead to hospital admission in older patients, according to Canadian researchers. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - December 23, 2014 Category: Nursing Source Type: news
